NCT06706570View on ClinicalTrials.gov

PIK3CA Mutational Status Assessment

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 6, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions
Breast Cancer Metastatic
Trial Locations (1)

20141

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER